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Drug-assisted interviews are useful for psychiatric diagnosis and treatment. However, amobarbital, a typical medication used for this pur-
pose, is associated with elevated risk of respiratory depression. Benzodiazepines are good substitutes for amobarbital, with similar therapeu-
tic effects and fewer complications. Although drug-assisted interviews are not widely used, they may be beneficial for selected patients who 
do not respond to conventional treatments such as supportive psychotherapy or psychopharmacotherapy. We report two cases of dissocia-
tive amnesia that were treated using lorazepam-assisted interviews. The use of lorazepam in drug-assisted interviews is effective and safe for 
resolving dissociative amnesia.  Psychiatry Investig 2011;8:377-380
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INTRODUCTION
Drug-assisted interviews are valuable diagnostic and thera-
peutic tools in psychiatry.
1-3 The main indications for drug-
assisted interviews are conditions such as catatonia, confu-
sion, conversion disorder, factitious disorder, mutism, and 
psychogenic amnesia. The standard method of drug-assisted 
interviews, the “Amytal interview” method, requires the use 
of a sedative, amobarbital, which is a medium-acting barbitu-
rate.
2,3 However, amobarbital demands careful attention due 
to the risk of respiratory depression.
4 Use of this technique is 
very limited due to the possible side effects of barbiturates 
and the lack of a specific reversing agent.
5
Benzodiazepines are a safer class of drug than barbiturates 
and are less likely to cause respiratory depression. An antago-
nist, flumazenil, is available. Therefore, benzodiazepines have 
been suggested as safer pharmacologic alternatives to barbitu-
rates for drug-assisted interviews.
6 Use of benzodiazepines 
such as midazolam, diazepam and lorazepam have been re-
ported for patients with various mental illnesses.
7-9 We report 
the safe and effective use of lorazepam in drug-assisted inter-
views in two cases of dissociative amnesia.
CASES
Case 1
An 18-year-old man was admitted to the psychiatry depart-
ment with aggressive and violent behavior one day prior to 
admission. However, he could remember nothing about his 
behavior or the violent incident. Forty-five days before hospi-
talization, he had experienced his first dissociative episode. 
After using a computer for an hour, he suddenly perceived 
that a photo board was covered with a mass of scribbles that 
was consisted of abusive language and the names of people 
whom he hated. Two weeks later, the patient experienced a 
second episode. While reading a martial arts novel, he noti-
ced that his book was torn. However he was not able to recall 
what happened. The day before admission, after finishing a 
test at school, the patient suddenly found himself sitting in a 
chair in the library on the 2nd floor about 100 meters away 
from his classroom on the 4th floor. The librarian, a young 
woman whom he knew from a book club, was bleeding from 
her head and was grabbing his collar. The police came to in-
vestigate. The patient was very embarrassed because he re-
portedly could not remember what had happened to her. 
On admission to the psychiatric unit, the patient was dys-378  Psychiatry Investig 2011;8:377-380
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phoric and felt guilty. He stated, “I cannot remember any-
thing.” Although he described ideas of reference and hearing 
the screams of monsters, his reality testing were within nor-
mal range. No other specific psychopathologies were found. 
Laboratory examinations and radiological studies of the pa-
tient’s brain yielded normal results. He denied drinking alco-
hol or using drugs.
The patient had been raised by his great aunt since the di-
vorce of his parents when he was 4 years old and had not kept 
in touch with his parents. His great aunt had not been care-
fully tuned to his emotional or physical development, and he 
felt that he had been neglected. the patient was shy and intro-
verted and seldom expressed emotion. At 6 months prior to 
his first amnestic episode, he had contacted his father and de-
cided to live with him, who had remarried, and his father’s 
new wife. However, he reported experiencing conflicts with 
his stepmother and might have reexperienced the past ne-
glect. We hypothesized that he had repressed aggression de-
rived from unfulfilled wishes for love and it was discharged as 
symptoms of amnestic syndrome, which may have been pre-
cipitated by some traumatic experience. 
The patient was diagnosed with “dissociative amnesia” and 
treated with fluoxetine 20 mg. His emotions and mood stabi-
lized within 5-7 hospital days. He attended several sessions of 
supportive psychotherapy that included reassurance and a 
nondirective approach in order to assist him in integrating his 
amnestic memory with associated emotions. We also tried to 
interpret the transference relation. However, he made no spe-
cific advances toward recovering his memories, and was en-
countering legal problems for the violent behavior toward the 
librarian. Therefore we decided to use a drug-assisted inter-
view to assist in recovering his memories of the dissociative 
incident. Informed consent was obtained. Two psychiatrists 
participated as interviewers, and an anesthesiologist moni-
tored and recorded his clinical state during the interview. The 
interview was performed according to the protocol that was 
made up by the authors on the basis of the references (Table 
1).
7,9,10 During the drug-assisted interview, the patient was 
able to recall memories that precipitated the incident. He stat-
ed that he loved the victim, the librarian. The day before this 
episode, he confessed to her that he loved her, but was reject-
ed. The interview lasted approximately one hour. As soon as 
the drug-assisted interview ended, the patient fell into a deep 
sleep. The day after his interview, he was able to recall por-
tions of what he had said during the drug-assisted interview 
and his actions during his dissociative state. As several days 
passed, he gradually remembered more about the incident. 
He also appeared more depressed and reported experiencing 
anxiety. Oral alprazolam 0.25 mg twice a day was added to his 
medications. After his depressed mood and anxiety had im-
Table 1. The protocol used for lorazepam-assisted interviews
Preparation
·Informed consent is obtained.
·The patient is placed in a reclining position. 
·The patient is maintained on an intravenous drip of 500 cc of 5% dextrose.
·An emergency kit and pulse oximetry are prepared. 
·Lorazepam 10 mg in N/S 300 cc and flumazenil are available.
Procedure
·Pulse oximetry and vital signs are monitored.
· Induction of hypnosis: Lorazepam is slowly administered intravenously at 0.05 mg/min until the patient shows 
  mild drowsiness and lateral nystagmus.
· Maintenance of hypnosis: During the interview, the administration of lorazepam can be adjusted from 0.05 mg/min 
  to 0.1 mg/min. The patient is observed for relaxation and sleepiness so that s/he does not fall asleep and is encouraged  
  to engage with the interview continuously. 
· Closing of the interview: After 45 minutes, the rate of lorazepam is decreased to less 0.05 mg/min and is stopped when 
  60 minutes have passed. 
· The exact amount of lorazepam administered and the administration rate depend on patient response, vital signs and 
  percentage of oxygen saturation. 
·Lorazepam is withheld if the oxygen saturation drops below 85%. 
·Flumazenil 0.1 mg/mL is immediately injected to reverse oversedation and respiratory depression if they occur.
Termination
· The patient should maintain absolute bed rest for an additional 15-30 minutes after the interview is over and be closely observed 
  for vital signs and oxygen saturation.SS Lee et al. 
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proved, he was discharged in 36 hospital days.
Case 2
A 17-year-old woman was admitted to the psychiatric de-
partment with amnesia. She was in the 3rd degree of high 
school and majored in playing the trumpet. One day before 
admission, she was violently attacked and almost kidnapped 
by a robber on the way home from school, but was rescued by 
witnesses of the attack. She developed a great deal of anxiety 
and was unable to remember any events from the time of her 
high school entrance to the traumatic event. She also was un-
able to remember how to play the trumpet, an instrument 
that she had played for the past three years. We performed a 
thorough medical work-up. There were no abnormal findings 
to explain her amnesia. We treated her with psychotropics 
(alprazolam 1.5 mg/day and paroxetine 20 mg/day) and sup-
portive psychotherapy. Her mood stabilized and her anxiety 
lessened. However, her amnesia persisted. We hypothesized 
that a lorazepam-induced interview could facilitate release of 
the emotional tension. Informed content was obtained. We 
conducted a lorazepam-induced interview according to our 
protocol (Table 1). During the interview, the patient reported 
that her parents expected her to enter an elite secondary 
school after she graduated middle school. However, her aca-
demic achievement did not meet her parents’ expectations, 
and she felt guilty. She said she had instead attended a voca-
tional high school. However her parents continuously insisted 
that she should continue to university. The patient reported 
that she “desperately did her best” in order to obtain her par-
ents’ approval. As part of these efforts, she changed her major 
to trumpet in pursuit of continuing to university. However 
she was not able to play the trumpet well enough to enter uni-
versity. She reported feeling increasing guilt and hostility to-
ward her parents as time went on. With the help of the drug-
assisted interview, the patient was encouraged to fully express 
her hostility and guilt toward her parents. After two sessions 
of drug-assisted interviews she was able to recall almost all 
episodic and procedural memories that had been dissociated 
from her consciousness. She was discharged with restored 
memory in 24 hospital days.
DISCUSSION
Dissociative amnesia is “an inability to recall important per-
sonal information, usually of a traumatic or stressful nature, 
that is too extensive to be explained by ordinary forgetful-
ness.”
11 Drug-assisted interviews in psychiatry have been used 
for 80 years and their usefulness in both diagnostic and thera-
peutic roles has been explored.
2,12
We reported two cases of dissociative amnesia. Neither pa-
tient responded to conventional supportive psychotherapy or 
psychopharmacotherapy. In particular, the first case required 
swift resolution of his selective amnesia due to legal implica-
tions. Through lorazepam-assisted interviews, we were able to 
recall repressed memories with associated emotions in both 
cases. 
Barbiturates are part of the standard protocol for the treat-
ment of dissociative amnesia.
2 However, due to side effects of 
respiratory depression and significant interactions with cen-
tral nervous system drugs, we chose to use a benzodiazepine 
instead.
2-5 Lorazepam yields similar results to barbiturates 
when used for drug-assisted interviews. Thus, we used loraze-
pam for these cases. 
From the perspective of neurocognitive science, functional 
amnestic patients have state-dependent activity.
13 The medial 
temporal and diencephalon memory retrieval mechanism is 
inhibited when trying to recall traumatic memories in such 
patients.
14 In a resting state, mnestic block syndrome is sus-
tained in the form of functional dissociation of the fronto-
temporal regions through the release of stress hormones.
15 
From a neurobiological perspective, functional amnesia is as-
sociated with increased activity of N-Methyl-D-aspartate (NM-
DA) receptors.
16 In our two cases, we postulated that lorazepam 
inhibited aroused prefrontal activity and NMDA receptor ac-
tivity during the drug-assisted interview.
Although it may not have been severe, the patient in case 1 
required further observation for impulsivity and disinhibition 
during the post-interview period.
9 The patient also showed 
mild depression and anxiety after the interview. Thus it is 
prudent to plan for the provision of support and reassurance 
in preparation for the interview. If the interview is recorded, it 
may be helpful to show the recordings to patients if the patient 
experiences more amnesia during the interview.
17
In conclusion, the use of lorazepam in drug-assisted inter-
views is very effective and safe for resolving dissociative am-
nesia.
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